Stockscreener 앱 받기
43.82
1.80%
-0.7968
전일 마감가:
$44.62
열려 있는:
$45.22
하루 거래량:
6.55M
Relative Volume:
0.32
시가총액:
$65.15B
수익:
$20.62B
순이익/손실:
$3.56B
주가수익비율:
18.38
EPS:
2.3847
순현금흐름:
$3.48B
1주 성능:
-2.13%
1개월 성능:
-2.53%
6개월 성능:
-50.25%
1년 성능:
-58.13%
1일 변동 폭
$43.77
$45.25
1주일 범위
$42.20
$45.45
52주 변동 폭
$42.20
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
43.83 | 66.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
99.86 | 172.14B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
318.81 | 126.97B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
82.78 | 106.96B | 36.36B | 4.84B | 5.43B | 3.7261 |
EW
Edwards Lifesciences Corp
|
85.93 | 50.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific stock trades steadily as Q1 2026 growth and cardiology portfolio underpin valuatio - ad-hoc-news.de
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Boston Scientific Expands Medical Device R&D in Ireland With €75 Million Investment - Assembly Magazine
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Boston Scientific stock hits 52-week low at 42.24 USD By Investing.com - Investing.com South Africa
Boston Scientific stock hits 52-week low at 42.24 USD - Investing.com
Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside - Yahoo Finance
Why Is Boston Scientific (NYSE:BSX) Growing Medical Technology? - Kalkine Media
Boston Scientific Corp (BSX) Shares Fall 4.5% -- What GF Score o - GuruFocus
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific Slides as WATCHMAN Slowdown Concerns and Fresh Target Cuts Weigh on Shares - Quiver Quantitative
Boston Scientific stock reflects steady medtech demand - ad-hoc-news.de
Disposable Endoscopes Market Size Projected to Hit USD 10.47 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Boston Scientific stock reflects steady growth outlook as medical device demand expands - ad-hoc-news.de
Boston Scientific Corporation (BSX) Is A Stock To Buy According To D. E. Shaw - Yahoo Finance
Daily Brief Health Care: Pharmaron, Ziyond Pharmaceutical, Boston Scientific and more - Smartkarma
Daily Brief United States: Netflix Inc, Autozone Inc, Boston Scientific, Ecolab Inc, Enterprise Products Partners, Global X Uranium ETF, Gold, Harley Davidson, Lennar Corp A, Mohawk Industries and more - Smartkarma
Boston Scientific Top Brass Sued Over Pacemaker Recall - Law360
BN stock holds steady as Boston Scientific grows its medtech base - ad-hoc-news.de
Is Boston Scientific (NYSE:BSX) Due For A Rebound? - Kalkine Media
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Yahoo Finance
Prosight Management, LP's Boston Scientific Corp(BSX) Holding History - GuruFocus
Federated Hermes Kaufmann Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Boston Scientific (NYSE:BSX) Climbs As Cardiology Demand Expands - Kalkine Media
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
BSX Maintained by Needham -- Price Target Lowered to $57.00 - GuruFocus
Needham cuts Boston Scientific stock price target on WATCHMAN sales By Investing.com - Investing.com South Africa
Needham cuts Boston Scientific stock price target on WATCHMAN sales - Investing.com
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific focuses on cardiovascular innovation as medical device demand grows - AD HOC NEWS
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
Is Boston Scientific (BSX) Still One of the Best Stocks to Invest In After Jefferies Slashed Its Target? - Yahoo Finance
BSXBoston Scientific Corp Volatility & Greeks - Finviz
Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump - Yahoo Finance
Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX) - Seeking Alpha
Munro Partners's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp. highlights minimally invasive care. Long-term demand supports its medical te - Ad-hoc-news.de
Boston Scientific Corp (NYSE:BSX) Offers Strong Value with High Profitability and Solid Growth - ChartMill
Boston Scientific Announces Software Upgrade for Pacemakers Amid Recall - GuruFocus
BSX Stock | Boston Scientific Corp Q1 2025 Earnings Call Bear Attack (FjRIiYMEgO) - Mshale
Boston Scientific stock hits 52-week low at 61.23 USD - Investing.com
Boston Scientific Corp (BSX) Stock Up 4.8% and Still Undervalued -- GF Score: 74/100 - GuruFocus
Form 4 Boston Scientific Corp For: 2 July By Investing.com - Investing.com India
Boston Scientific (BSX) CFO reports RSU conversion and tax-withheld shares - Stock Titan
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Stifel Cuts PT on Boston Scientific Corporation (BSX)- Here’s Why - Insider Monkey
List of 57 Acquisitions by Boston Scientific (Jul 2026) - Tracxn
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.27%
자본화:
|
볼륨(24시간):